Chargement en cours...
Position of Scientific Oncological Societies Towards Biosimilar Antibodies
First biosimilars of monoclonal antibodies have recently been approved in oncology. Biosimilars enable economic competition, alleviate the financial burden for insurances, and may facilitate access to these drugs in low-income countries. Biosimilars are not completely identical to the original drug....
Enregistré dans:
| Publié dans: | Breast Care (Basel) |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
S. Karger GmbH
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465735/ https://ncbi.nlm.nih.gov/pubmed/31019436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495145 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|